Holen Sie sich die Stockscreener-App
35.17
0.80%
0.28
Handel nachbörslich:
35.17
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Qiagen N.V. stock (NL0012169213): Jefferies cuts target as diagnostics group navigates post-pandemic - AD HOC NEWS
Qiagen N.V. stock (NL0012169213): oncology ramp and new diagnostics deals put focus on growth mix - AD HOC NEWS
Release according to Article 40, Section 1 of the WpHG - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen N.V. stock (NL0012169213): Legal probes and price drop unsettle investors - AD HOC NEWS
Qiagen N.V. stock (NL0012169213): Diagnostics group updates investors after solid Q1 2026 - AD HOC NEWS
QGEN Stock Price, Quote & Chart | QIAGEN N.V. (NYSE:QGEN) - ChartMill
Qiagen N.V. Stock 12‑Month Price Target Cut to $42.04, Implies 20% Upside - TradingView
Qiagen stock (NL0012169213): Shares rise after Q1 update and guidance reaffirmation - AD HOC NEWS
QIAGEN Stock Up on the Launch of AI-Powered Workflow Agent Platform - TradingView
Qiagen N.V. stock (NL0012169213): Outlook raised after Q1 2026 update and new AI assistant launch - AD HOC NEWS
QIAGEN NV cuts FY outlook despite in-line prelim Q1 EPS - MSN
QIAGEN Discloses Million-Dollar Insider Share Purchase by Supervisory Board Member Trust - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen launches AI assistant for laboratory research By Investing.com - Investing.com South Africa
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows - BioSpace
Qiagen N.V. (QGEN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Qiagen stock (NL0012169213): Q1 update and share-price backdrop - AD HOC NEWS
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflo - PharmiWeb.com
Qiagen launches AI assistant for laboratory research - Investing.com
New QIAGEN AI lab assistant is designed to speed experiment planning - Stock Titan
QIAGEN launches AI assistant for laboratory workflow support - StreetInsider
Qiagen N.V. stock (NL0012169213): Diagnostics group lifts 2026 outlook after first?quarter earnings - AD HOC NEWS
Qiagen N.V. stock (NL0012169213): steady earnings backdrop as shares lag 2026 highs - AD HOC NEWS
Qiagen (QGEN) Securities Fraud InvestigationLevi & Korsinsky - PR Newswire
QIAGEN and NVIDIA partner on AI drug discovery - Yahoo Finance
Qiagen Faces Legal Review As QuantiFERON Outlook Shifts And Valuation Draws Focus - Sahm
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA - BioSpace
Qiagen stock (NL0012169213): Q1 update keeps diagnostics and life-science demand in focus - AD HOC NEWS
QIAGEN partners with NVIDIA on AI drug discovery platform By Investing.com - Investing.com Nigeria
QIAGEN partners with NVIDIA on AI drug discovery platform - Investing.com UK
QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V. - Business Wire
QIAGEN partners with NVIDIA to integrate AI into drug discovery platform - StreetInsider
Bank of America Discloses 2.98% Stake in Qiagen via AFM Filing - The Globe and Mail
Qiagen's Digital Insights Business to Integrate Nvidia's BioNeMo Platform - marketscreener.com
Qiagen discloses AFM notification on 2.99% Bank of America stake - TipRanks
Qiagen N.V. stock (NL0012169213): earnings outlook and molecular diagnostics focus - AD HOC NEWS
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $36 - Moomoo
Citigroup downgrades Qiagen NV (QGEN) - MSN
Qiagen N.V. stock (NL0012169213): diagnostics specialist updates investors after Q1 results - AD HOC NEWS
QGEN Maintained by Stifel -- Price Target Lowered to $36 - GuruFocus
Qiagen stock (NL0012169213): New strategic tie-up puts diagnostics in focus - AD HOC NEWS
Qiagen N.V. (QGEN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Stifel cuts Qiagen stock price target to $36 on weaker outlook By Investing.com - Investing.com Australia
Qiagen stock (NL0012169213): QIAGEN’s U.S. diagnostics exposure stays in focus - AD HOC NEWS
Stifel cuts Qiagen stock price target to $36 on weaker outlook - Investing.com Australia
Qiagen NV (QGEN) PT Lowered to $36 at Stifel on 'Lower Growth Outlook' - StreetInsider
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $36 - Moomoo
Qiagen N.V. (QGEN) Investor Outlook: A 32.87% Upside Potential in the Diagnostics & Research Sector - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Is Investigating Qiagen N.V. (QGEN) And Encourages Investors to Connect - ACCESS Newswire
Qiagen N.V. stock (NL0012169213): earnings momentum and diagnostics demand keep investors watching - AD HOC NEWS
Qiagen N.V. stock (NL0012169213): Q1 2026 earnings and outlook keep diagnostics specialist in focus - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Encourages Qiagen N.V. (QGEN) - The National Law Review
Law firm investigates Qiagen over potential securities law violations after stock drops 11%. - Pluang
QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V. on ... - Herald and News
0.72%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):